Toggle light / dark theme

Making aquafeed more sustainable: Scientists develop feeds using a marine microalga co-product

Dartmouth scientists have created a more sustainable feed for aquaculture by using a marine microalga co-product as a feed ingredient. The study is the first of its kind to evaluate replacing fishmeal with a co-product in feed designed specifically for Nile tilapia. The results are published in the open access journal, PLOS ONE.

Aquaculture is the world’s fastest growing food sector, surpassing the global capture fisheries production in 2014. It provides more than 50 percent of the food supply to humans; however, it poses several environmental concerns. Aquaculture feed (aquafeeds) draws on 70 percent of the world’s and , which is obtained from small, ocean-caught fish such as anchovies, sardines, herring, menhaden, and mackerel¬, that are essential to the lower end of the . Analysts project that by 2040, the demand for fishmeal and fish oil will exceed supply. Aquafeeds also draw on large amounts of soy and corn from industrial farms, which pose other environmental concerns due to the use of fertilizers and potential runoff into rivers, lakes and coastal waters. In addition, aquafeeds may trigger nutrient pollution in aquaculture effluent, as fish are unable to fully digest soy and corn, which are major feed ingredients.

To address the environmental sustainability concerns regarding aquafeed, a Dartmouth team has been developing sustainable feeds for Nile tilapia, which examine the effectiveness of replacing fishmeal and fish oil with different types of marine microalgae. Marine microalgae are excellent sources of , minerals, vitamins, and omega-3 fatty acids, and can therefore, meet the nutrient requirements of fish. Omega-3 fatty acids are important for maintaining fish health; they also have neurological, cardiovascular and anti-cancer benefits to humans.

The State of Brain-Machine Interfaces — Prof. Maryam Shanechi

Maryam shanechi, university of southern california.

With recent technological advances, we can now record neural activity from the brain, and manipulate this activity with electrical or optogenetic stimulation in real time. These capabilities have brought the concept of brain-machine interfaces (BMI) closer to clinical viability than ever before. BMIs are systems that monitor and interact with the brain to restore lost function, treat neurological disorders, or enhance human performance.

February 2018

A review and implications for aging research

The effects of donor age on organ transplants: A review and implications for aging research.


Despite the considerable amount of data available on the effect of donor age upon the outcomes of organ transplantation, these still represent an underutilized resource in aging research. In this review, we have compiled relevant studies that analyze the effect of donor age in graft and patient survival following liver, kidney, pancreas, heart, lung and cornea transplantation, with the aim of deriving insights into possible differential aging rates between the different organs. Overall, older donor age is associated with worse outcomes for all the organs studied. Nonetheless, the donor age from which the negative effects upon graft or patient survival starts to be significant varies between organs. In kidney transplantation, this age is within the third decade of life while the data for heart transplantation suggest a significant effect starting from donors over age 40. This threshold was less defined in liver transplantation where it ranges between 30 and 50 years. The results for the pancreas are also suggestive of a detrimental effect starting at a donor age of around 40, although these are mainly derived from simultaneous pancreas-kidney transplantation data. In lung transplantation, a clear effect was only seen for donors over 65, with negative effects of donor age upon transplantation outcomes likely beginning after age 50. Corneal transplants appear to be less affected by donor age as the majority of studies were unable to find any effect of donor age during the first few years posttransplantation. Overall, patterns of the effect of donor age in patient and graft survival were observed for several organ types and placed in the context of knowledge on aging.

Do you want to join in the fight to end age-related disease?

Together, Forever Healthy Foundation and SENS Research Foundation are now accepting research proposals that promise progress in regenerative medicine for the prevention and reversal of age-related disease. This Fellowship will take place at SRF’s research center in Mountain View, California.

For more information, please visit: http://sens.org/research/research-blog/forever-healthy-found…technology

The Dark Secret These Corporations Are Hiding From You

This is a must watch video. It tells a painful truth of our real world. It is worth the watch. Please pass this video along if you are so inclined.


Excerpt: You live in a world of drug dealers. Only the drugs can be bought legally, and are perfectly priced to prevent you from inquiring into other areas. Your society exhibits a wealth of negative side effects from these drugs. Yet the bulk of your population still continues to use our products, even after they’ve shown themselves to be harmful. You live in a population that continues to grow more restless, agitated, and depressed, in part from eating our goodies and treats. Treats that are called “superstimuli” as the stimulus it produces inside your brain vastly exceeds the natural stimuli humans received throughout evolution, from natural foods.

*** I do this full time with the help of your donations or patronage. Your help is profoundly appreciated, and truly does help these videos continue, thank you!

Aubrey de Grey — We Will End Aging

Website ► http://sens.org
YouTube ► https://www.youtube.com/user/SENSFVideo
Facebook ► https://www.facebook.com/sensf
Twitter ► https://twitter.com/senstweet

“At SENS Research Foundation, we believe that a world free of age-related disease is possible. That’s why we’re funding work at universities across the world and at our own Research Center in Mountain View, CA.

Our research emphasizes the application of regenerative medicine to age-related disease, with the intent of repairing underlying damage to the body’s tissues, cells, and molecules. Our goal is to help build the industry that will cure the diseases of aging. ”

Aubrey de Grey ► http://goo.gl/Tc5QHl

Aubrey David Nicholas Jasper de Grey is an English author and theoretician in the field of gerontology and the Chief Science Officer of the SENS Research Foundation. He is editor-in-chief of the academic journal Rejuvenation Research, author of The Mitochondrial Free Radical Theory of Aging (1999) and co-author of Ending Aging (2007). He is known for his view that medical technology may enable human beings alive today to live to lifespans far in excess of any existing authenticated cases.

De Grey’s research focuses on whether regenerative medicine can thwart the aging process. He works on the development of what he calls “Strategies for Engineered Negligible Senescence” (SENS), a collection of proposed techniques to rejuvenate the human body and stop aging. To this end, he has identified seven types of molecular and cellular damage caused by essential metabolic processes. SENS is a proposed panel of therapies designed to repair this damage.